We are live on ! Find out more
CVRS

Corindus Vascular Robotics
CVRS

Delisted

CVRS was delisted on the 28th of October, 2019.

41 hedge funds and large institutions have $127M invested in Corindus Vascular Robotics in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

212% more capital inflows, than outflows

Capital inflows: $10.9M | Capital outflows: $3.5M

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

5% more funds holding

Funds holding: 39 → 41 (+2)

1.24% more ownership

Funds ownership: 35.57% → 36.81% (+1.2%)

7% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 15

Holders
41
Holders Change
+2
Holders Change %
+5.13%
% of All Funds
1.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
16
Reduced
15
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

CVRS Hedge Fund Activity: Q3 2015 in Review

41 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Corindus Vascular Robotics (CVRS) for Q3 2015, worth a combined $127M — down 13% from $146M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new CVRS positions and 2 closed out — a net gain of 2 holders — while 16 added to existing stakes and 15 trimmed.

The largest buyer was Vanguard Group, adding an estimated $4.3M. The largest seller was Wellington Management Group, cutting an estimated $3.01M.

  • 41 institutional investors held Corindus Vascular Robotics (CVRS) as of Q3 2015, up from 39 in Q2 2015.
  • Funds reported $127M of Corindus Vascular Robotics stock for Q3 2015, down 13% quarter-over-quarter.
  • 4 funds opened new Corindus Vascular Robotics positions in Q3 2015 and 2 closed out, a net change of +2 holders.
  • The largest Corindus Vascular Robotics buyer in Q3 2015 was Vanguard Group, an estimated $4.3M added.
  • The largest Corindus Vascular Robotics seller in Q3 2015 was Wellington Management Group, an estimated $3.01M sold.

Based on aggregated 13F filings for Q3 2015.